Finnish diabetes vaccine trials to start in 2018 | Yle Uutiset |

A vaccine for type 1 diabetes developed by Finnish researchers will be tested on mainly Finnish human subjects in late 2018.

A virus may be behind a significant proportion of type 1 diabetes cases, which are especially common among children. Researchers are confident that an enterovirus that attacks the pancreas to destroy insulin-producing cells is the root cause of type 1 diabetes. Enteroviruses are the most common type of infectious virus in humans; they cause a wide variety of health problems.


Be the first to post a comment.

Leave a Comment

Your email address will not be published. Required fields are marked *